dalteparin has been researched along with Antithrombin III Deficiency in 9 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Antithrombin III Deficiency: An absence or reduced level of Antithrombin III leading to an increased risk for thrombosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Due to the expense associated with ATIII, a capped dosing approach for ATIII was evaluated in this population." | 1.51 | Capped antithrombin III dosing is cost effective in the management of asparaginase-associated thrombosis. ( Breese, EH; Jenkins, M; Luchtman-Jones, L; O'Brien, M; Sawyer, J; Young, J, 2019) |
| "Untreated hereditary antithrombin deficiency in pregnancy is associated with maternal venous thromboembolism (VTE) and possibly with fetal loss." | 1.39 | How I treat heterozygous hereditary antithrombin deficiency in pregnancy. ( Bramham, K; Hunt, BJ; Mitchell, M; Moore, GW; Retter, A; Robinson, SE, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Llau, JV | 1 |
| Hoyas, L | 1 |
| Ezpeleta, J | 1 |
| García-Polit, J | 1 |
| Brinks, HJ | 1 |
| Weerwind, PW | 1 |
| Verkroost, MW | 1 |
| Nováková, I | 1 |
| Brouwer, MH | 1 |
| Young, J | 1 |
| Sawyer, J | 1 |
| Jenkins, M | 1 |
| O'Brien, M | 1 |
| Luchtman-Jones, L | 1 |
| Breese, EH | 1 |
| Bramham, K | 1 |
| Retter, A | 1 |
| Robinson, SE | 1 |
| Mitchell, M | 1 |
| Moore, GW | 1 |
| Hunt, BJ | 1 |
| Cohen, HV | 1 |
| Gurung, S | 1 |
| Quek, SY | 1 |
| Subramanian, G | 1 |
| Abbas, A | 1 |
| Clark, ER | 1 |
| English, JC | 1 |
| Kenny, B | 1 |
| Volobuev, V | 1 |
| Macklon, NS | 1 |
| Greer, IA | 1 |
| Reid, AW | 1 |
| Walker, ID | 1 |
| Ellis, MH | 1 |
| Manor, Y | 1 |
| Witz, M | 1 |
1 review available for dalteparin and Antithrombin III Deficiency
| Article | Year |
|---|---|
Blood clots. Good when you're bleeding; bad when you're not bleeding hypercoagulability and thrombophilia--overview and case report.
Topics: Adult; Anticoagulants; Antithrombin III Deficiency; Blood Coagulation; Dental Care for Chronically I | 2014 |
8 other studies available for dalteparin and Antithrombin III Deficiency
| Article | Year |
|---|---|
[Use of low molecular weight heparins].
Topics: Anesthesia, Epidural; Anesthesia, Obstetrical; Anticoagulants; Antithrombin III Deficiency; Cesarean | 1997 |
Familial antithrombin-III deficiency during cardiopulmonary bypass: a case report.
Topics: Animals; Antithrombin III; Antithrombin III Deficiency; Blood Loss, Surgical; Cardiopulmonary Bypass | 2000 |
Capped antithrombin III dosing is cost effective in the management of asparaginase-associated thrombosis.
Topics: Adolescent; Adult; Anticoagulants; Antithrombin III; Antithrombin III Deficiency; Asparaginase; Chil | 2019 |
How I treat heterozygous hereditary antithrombin deficiency in pregnancy.
Topics: Adult; Antithrombin III; Antithrombin III Deficiency; Drug Administration Schedule; Enoxaparin; Fema | 2013 |
Thrombosis-induced ulcerations of the lower legs with coexistent anetoderma due to anti-thrombin III deficiency.
Topics: Anetoderma; Antithrombin III Deficiency; Enoxaparin; Humans; Leg Ulcer; Thrombosis | 2011 |
Splenic rupture following elective caesarean delivery at term, complicated by low-molecular-weight heparin use.
Topics: Abdominal Pain; Adult; Anticoagulants; Antithrombin III Deficiency; Cesarean Section; Comorbidity; E | 2007 |
Thrombocytopenia, antithrombin deficiency and extensive thromboembolism in pregnancy: treatment with low-molecular-weight heparin.
Topics: Adult; Antithrombin III; Antithrombin III Deficiency; Enoxaparin; Female; Fetal Death; Heparin; Huma | 1995 |
Risk factors and management of patients with upper limb deep vein thrombosis.
Topics: Activated Protein C Resistance; Adult; Aged; Antithrombin III Deficiency; Drug Therapy, Combination; | 2000 |